Evidence map›Paper›PMID 24563595›Full record

ArticleJournal of young pharmacists : JYP2013

Synthesis, characterisation and evaluation of N-mannich bases of 2-substituted Benzimidazole derivatives.

Sekar Vinoth Kumar, Mohan Raj Subramanian, Santhosh Kumar Chinnaiyan

Open access · greenAbstract read
In one paragraph

Article in Journal of young pharmacists : JYP, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sekar Vinoth KumarDepartment of Pharmaceutical Chemistry, Gokulakrishna College of Pharmacy, Andhra Pradesh 524121, India.
Mohan Raj SubramanianDepartment of Pharmacology, SSM College of Pharmacy, Tamil Nadu 638312, India.
Santhosh Kumar ChinnaiyanDepartment of Pharmaceutical Biotechnology, Srikrupa Institute of Pharmaceutical Sciences, Andhra Pradesh 502277, India.
SRM Dental College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleBenzimidazoles and its derivatives represent one of the mainly biological active classes of literature.

aimIn this present study aimed to synthesize N-mannich bases derivatives compounds bearing of 2-substituted benzimidazole moiety, in order to investigate their possible biological activity.

methodBenzimidazole compounds were prepared from the condensation reaction between ortho phenylene diamine and various acids. Mannich base of newly synthesized Benzimidazole derivatives were synthesized from 2-substituted Benzimidazoles by reacting with secondary amines. The purity of the compounds was ascertained by melting point (m.p) and thin layer chromatography (TLC). Structures of the synthesized compounds were elucidated by spectral data. Antimicrobial assay was performed by microbroth dilution method. Bacterial genomic DNA cleavage was assessed by Agarose gel electrophoresis. Toxicity of the most effective compounds was studied by Brine-shrimp lethality assay.

resultAmong the synthesized compounds, compound 5E (a) and (b) was establish to be the most potent against all tested microorganisms. This two compounds exhibited complete bacterial DNA cleavage and non-toxic.

conclusionThese results suggest that it an interesting compound compared to the current therapeutic agents and are considered to investigate further for the same.

Indexed as

BenzimidazolesBrine-shrimp lethalityMannich baseMicrobroth dilutionO-Phenylene diamine

Identifiers

PMID24563595
PMCPMC3930114
OpenAlexW2084358874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.